Strive, Inc. (ASST) financials
NASDAQ · Financial Services · Asset Management · 28 employees · CEO Matthew Ryan Cole
- Price
- $21.45 +4.18%
- Market cap
- $2.34B
- Enterprise value
- $2.06B
- Last report
- Q3 '26 filed 2026-11-06
Valuation & key figures
- Market cap
- $2.34B EV $2.06B
- Revenue
- $9.91M Trailing 12 months
- Revenue growth
- +105% FY2026 consensus
- Profit margin
- -4,728.2% Net income / revenue, TTM
- P/E
- -2.8× Forward -35.5× (FY2026)
- P/S
- 235.9× Price / sales, TTM
- EV / EBITDA
- 4.7× TTM
- Free cash flow
- -$64.4M Trailing 12 months
- Net income
- -$469M Trailing 12 months
- Revenue estimate
- $11.8M FY2026 consensus
- Earnings
- –
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-11-06): revenue missed by 10.1%, EPS beat by 73.6%Revenue $2.7M vs $3M expected (-10.1%); EPS $5.33 vs $3.07 (+73.6%).
- Revenue growth accelerating: 74.7% year on yearQ3 '26 revenue $2.7M, against an average of 72.9% over the four quarters before.
- Operating margin 4,408.2% (TTM), +5,057.3 pp on a year agoOperating income grew 1,321.0% while revenue grew 79.8%.
- Capex 0.1% of revenue (a year ago 0.1%)$12K invested in the last 4 quarters (+335.3% on a year earlier). Free cash flow -$64.4M.
- Diluted share count up 5,330.6% in a year90.5M diluted shares in Q3 '26, 1.67M a year earlier.
- Net cash $332MCash + short-term investments $336M, debt incl. leases $3.22M; a year ago net cash $102M.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $2.7M | $1.54M | +74.7% |
| Gross margin | -479.9% | 96.4% | -576.3 pp |
| Operating income | $508M | -$23.3M | +2,278.7% |
| Operating margin | 18,843.6% | -1,511.2% | +20,354.8 pp |
| Net income | $475M | -$207M | +329.8% |
| Diluted EPS | $5.24 | -$124.00 | +104.2% |
| Operating cash flow | $0 | -$28.9M | +100.0% |
| Capex | $0 | $3 | -100.0% |
| Free cash flow | $0 | -$28.9M | +100.0% |
| R&D | $14.7M | $0 | – |
| Stock-based compensation | $6.52M | $0 | – |
Reported vs consensus
2026-11-06| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $2.7M | $3M | -10.1% |
| EPS (as estimated) | $5.33 | $3.07 | +73.6% |
From the report of 2026-11-06 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Investment Advice | $1.51M | – | 97.4% | – | – | |
| Product and Service, Other | $41K | – | 2.6% | – | – |
Segment profits
Operating income per reported segment, read from the segment note of each 10-Q / 10-K (the profit split most data feeds leave out).
Segments in Q3 '26
| Segment | Revenue | y/y | Operating income | y/y | Margin | Margin a year ago | TTM operating income |
|---|---|---|---|---|---|---|---|
| Asset Management Segment | $1.56M | – | -$1.99M | – | -127.7% | – | – |
| Medical Device Segment | $1.13M | – | -$19.8M | – | -1,751.2% | – | – |
| Corporate And Other | – | – | – | – | – | – | – |
| Bitcoin Operations Segment | $4K | – | $530M | – | 13,246,400.0% | – | – |
Operating income by segment
quarterlySegment operating margin
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- -$64.4M
- Capex
- -$12K
- Buybacks
- $500K
- Dividends
- $0
- Acquisitions
- $0
- Net debt issued
- -$20.3M
- Stock-based compensation
- $18.7M
- Free cash flow
- -$64.4M
- Returned to shareholders / FCF
- 0.8%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | -2.8× | 147.9× 1 of 5 years | 147.9× – 147.9× |
| EV / EBITDA | 4.7× | 43.4× 4 of 5 years | 0.4× – 172.1× |
| EV / Sales | 207.4× | 5.5× 2 of 5 years | 3.1× – 8.0× |
| Price / FCF | -36.3× | – | – |
| Price / Book | 0.7× | 4.8× | 0.0× – 15.8× |
| FCF yield | -2.8% | -1,240.7% | -5,268.6% – 0.0% |
| Return on invested capital | 16.5% | -163.8% | -419.6% – 5.3% |
| Return on equity | -32.3% | -174.0% | -419.6% – 5.5% |
Analysts
Consensus target $34.25 (+59.7%)
range $30.00 – $38.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $11.8M | +105.2% | -$0.61 | +93.8% | -35.5× | 2 |
| FY2027 | $11.2M | -4.9% | $1.35 | +323.7% | 15.8× | 2 |
| FY2028 | $11.8M | +5.1% | -$0.53 | -139.2% | -40.5× | 1 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 164 figures Strive, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| $0 | – | – | – | – | – | |
| $0 | – | – | – | – | – | |
| Accounts Payable and Other Accrued Liabilities, Current | $7.36M | $9.19M | -19.9% | $8.56M | $2.23M | +284.4% |
| Accretion (Amortization) of Discounts and Premiums, Investments | $0 | – | – | $14K2024-12-31 | – | – |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $400K2025-12-31 | $200K | +100.0% | $400K | $200K | +100.0% |
| Additional Paid in Capital | $2B | $1.05B | +90.8% | $1.06B | $0 | – |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | $2.81M | – | – | – | – | – |
| Adjustments to Additional Paid in Capital, Warrant Issued | $02025-12-31 | – | – | – | – | – |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 27M | – | – | 1.1M2024-12-31 | – | – |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $6.52M | – | – | – | – | – |
| Assets | $2.68B | $793M | +238.7% | $746M | $28.2M | +2,544.0% |
| Assets, Current | $339M | $114M | +196.6% | $71.8M | $23.8M | +202.1% |
| Business Combination, Acquisition Related Costs | $0 | – | – | $02024-12-31 | – | – |
| Business Combination, Bargain Purchase, Gain Recognized, Amount | $0 | – | – | – | – | – |
| Cash Acquired from Acquisition | $0 | – | – | $02024-12-31 | – | – |
| Cash and Cash Equivalents, at Carrying Value | $285M | $109M | +161.7% | $67.5M | $6.16M | +996.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $285M | $109M | +161.7% | $67.5M | $6.16M | +996.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $140M | – | – | $4.07M2024-12-31 | – | – |
| CryptoAssetFairValueNoncurrent | $2.34B | $673M | +247.8% | $668M | $0 | – |
| CryptoAssetUnrealizedGainLossOperating | $534M | – | – | $02024-12-31 | – | – |
| Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | $1.65M | – | – | $02024-12-31 | – | – |
| DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent | $02025-12-31 | $16.8M | -100.0% | $0 | $16.8M | -100.0% |
| Deferred Tax Assets, Charitable Contribution Carryforwards | $46K2025-12-31 | $35K | +31.4% | $46K | $35K | +31.4% |
| Deferred Tax Assets, Gross | $75.8M2025-12-31 | $12.3M | +514.8% | $75.8M | $12.3M | +514.8% |
| Deferred Tax Assets, Net | $0 | $0 | – | $0 | $0 | – |
| Deferred Tax Assets, Net of Valuation Allowance | $1.13M2025-12-31 | $510K | +121.4% | $1.13M | $510K | +121.4% |
| Deferred Tax Assets, Operating Loss Carryforwards | $26.7M2025-12-31 | $11.7M | +128.2% | $26.7M | $11.7M | +128.2% |
| Deferred Tax Assets, Other | $02025-12-31 | $98K | -100.0% | $0 | $98K | -100.0% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $1.43M2025-12-31 | $0 | – | $1.43M | $0 | – |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | $02025-12-31 | $72K | -100.0% | $0 | $72K | -100.0% |
| Deferred Tax Assets, Valuation Allowance | $74.7M2025-12-31 | $11.8M | +531.7% | $74.7M | $11.8M | +531.7% |
| Deferred Tax Liabilities, Gross | $1.13M2025-12-31 | $510K | +121.4% | $1.13M | $510K | +121.4% |
| Deferred Tax Liabilities, Intangible Assets | $02025-12-31 | $9K | -100.0% | $0 | $9K | -100.0% |
| Deferred Tax Liabilities, Leasing Arrangements | $992K2025-12-31 | $375K | +164.5% | $992K | $375K | +164.5% |
| Deferred Tax Liabilities, Property, Plant and Equipment | $137K2025-12-31 | $126K | +8.7% | $137K | $126K | +8.7% |
| Depreciation, Depletion and Amortization | $78K | – | – | $192K2024-12-31 | – | – |
| Depreciation, Depletion and Amortization, Nonproduction | $78K | – | – | $192K2024-12-31 | $734 | +26,058.0% |
| Derivative, Gain (Loss) on Derivative, Net | $0 | – | – | $02024-12-31 | – | – |
| Dividends Payable, Current | $14M | – | – | $2.05M | $0 | – |
| Dividends, Preferred Stock | $34.2M | – | – | – | – | – |
| Earnings Per Share, Basic | $5.33 | – | – | -$9.752024-12-31 | -$1.85 | -427.0% |
| Earnings Per Share, Diluted | $5.24 | – | – | -$9.752024-12-31 | -$1.85 | -427.0% |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | – | – | – | -$4.53M2024-12-31 | -$1.04M | -337.6% |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | – | – | – | 21.0%2024-12-31 | 21.0% | 0.0% |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | – | – | – | $4.51M2024-12-31 | $763K | +490.9% |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | – | – | – | -20.9%2024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | – | – | – | $02024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent | – | – | – | 0.0%2024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | – | – | – | $21K2024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | – | – | – | -0.1%2024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Percent | 0.0% | – | – | 0.0%2024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | – | – | – | $02024-12-31 | – | – |
| Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | – | – | – | 0.0%2024-12-31 | – | – |
| Employee-related Liabilities, Current | $12.9M | $357K | +3,520.2% | $164K | $1.11M | -85.3% |
| Equity Securities, FV-NI | $50.2M | – | – | – | – | – |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | $8.83M | – | – | – | – | – |
| Finite-Lived Intangible Assets, Accumulated Amortization | -$100K2025-12-31 | -$100K | 0.0% | -$100K | -$100K | 0.0% |
| Gain (Loss) on Extinguishment of Debt | $0 | – | – | – | – | – |
| General and Administrative Expense | $6.67M | – | – | $11.2M2024-12-31 | $2.18M | +415.2% |
| Goodwill | $02025-12-31 | $0 | – | $0 | $0 | – |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-09